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Abstract. The 1997 and 2009 WHO dengue case classifications were compared in a systematic review with 12 eligible
studies (4 prospective). Ten expert opinion articles were used for discussion. For the 2009 WHO classification studies
show: when determining severe dengue sensitivity ranges between 59–98% (88%/98%: prospective studies), specificity
between 41–99% (99%: prospective study) - comparing the 1997 WHO classification: sensitivity 24.8–89.9% (24.8%/
74%: prospective studies), specificity: 25%/100% (100%: prospective study). The application of the 2009 WHO classifi-
cation is easy, however for (non-severe) dengue there may be a risk of monitoring increased case numbers. Warning signs
validation studies are needed. For epidemiological/pathogenesis research use of the 2009 WHO classification, opinion
papers show that ease of application, increased sensitivity (severe dengue) and international comparability are advanta-
geous; 3 severe dengue criteria (severe plasma leakage, severe bleeding, severe organ manifestation) are useful research
endpoints. The 2009 WHO classification has clear advantages for clinical use, use in epidemiology is promising and
research use may at least not be a disadvantage.
INTRODUCTION
The World Health Organization (WHO), with its Spe-
cial Program for Research and Training in Tropical Diseases
(WHO/TDR), issued new dengue guidelines in 2009,1 includ-
ing the 2009 WHO dengue case classification: dengue and
severe dengue (D/SD). Warning signs (WS) have been estab-
lished for triage to help clinicians with symptomatic cases
in need of closer surveillance and/or hospitalization (dengue
with warning signs [D+WS]).
Historically, the 1997 WHO dengue case classification
(dengue fever (DF), dengue hemorrhagic fever (DHF) and
dengue shock syndrome (DSS) was developed in 1975 by
expert consensus based on studies on Thai children in the
1950s and £60s, with modifications in 1986 and 1997.2 In the
last modification in 1997, four grades of DHF were defined
(DHF1, −2, −3, and −4), with DHF1 and −2 being DHF and
DHF3 and −4 being DSS.3
In this work, we will refer to the dengue case classifica-
tion recommended by the WHO in 2009 as the D/SD clas-
sification and the WHO 1997 classification as the DF/DHF/
DSS classification.
The reasons for developing D/SD were the shortcomings
of DF/DHF/DSS, which were established in many studies
and furthermore, summarized in a systematic review.2
DF/DHF/DSS (1) is poorly related to disease severity,
(2) misdirects clinicians identifying severe disease, (3) is
difficult to use (tests required are often not available/difficult
to apply), (4) does not help for triage in outbreaks, and
(5) leads to different reporting globally as a result of the
difficulties in using the classification for reporting clinicians.
The main emphasis of D/SD is, therefore, to help clini-
cians to identify and manage cases of severe dengue timely.
It helps to save resources and contributes to a reduction of
dengue mortality.
Based on the largest prospective multicenter study, the
Dengue and Control (DENCO) study,4 D/SD describes den-
gue as it currently occurs globally, focusing on severe dengue,
defined as plasma leakage (shock or fluid accumulation with
respiratory distress, which includes the former DSS), severe
bleeding, or severe organ manifestation. With the improved
description of dengue cases, case reporting is facilitated.
WS have been empirically validated to some extent in the
DENCO study. A larger study is currently under way to
evaluate and define the predictive value of WS in outpatients
(for the need of hospitalization) and inpatients (for severe
disease).5 Furthermore, D/SD is based on best available evi-
dence (evidence grade 1/2)6 on each step of the development
from basic to implementation research.7
A discussion evolved internationally on the usefulness
and applicability of D/SD compared with DF/DHF/DSS,
and in a relatively short period of time, numerous studies
have been published by many independent research groups.
The objective of this study is to provide a systematic litera-
ture review of the studies published, comparing D/SD and
DF/DHF/DSS to facilitate the discussion about the usefulness
of the different classification systems.
METHODS
Reporting items for systematic reviews and meta-analyses
(PRISMA) Statement for systematic reviews and meta-
analyses8 were followed. This study defines (1) case definition
as the description of clinical and laboratory parameters to
define a dengue case compared with other febrile illnesses
and (2) case classification as the different stages of the spec-
trum of dengue severity, either D, including D+WS, or SD.
Eligibility criteria included (1) research on dengue case
classification and/or dengue case definition, (2) comparison
of D/SD and DF/DHF/DSS, (3) any comparative/analytical
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study design, and (4) published after the publication of the
new WHO dengue guidelines.1
All languages were included; the search was conducted
in English only. Studies looking only at one classification
were excluded for failing to compare the different models.
Also excluded were studies not performed in dengue-endemic
countries. Studies without a defined methodology, including
expert opinion and conference proceedings, were collected
and used for the discussion.
The literature search and analysis were developed and
carried out through July 15, 2013 with two data extractors.
The search terms derived from two major categories were
(1) dengue disease (dengue) combined with (2) classification
and/or definition.
The search strategy was applied to the following data-
bases: US National Library of Medicine and the National
Institutes of Health Medical Database (PubMed), the Latin
American and Caribbean Health Sciences Database (Lilacs),
Excerpta Medica Database (EMBASE), and the Cochrane
Database of Systematic Reviews (CDSR). The WHO library
database (WHOLIS) and Google Scholar were searched for
grey literature. Relevant literature was screened for addi-
tional articles in the reference sections.
Because of the limited search options available to this
field of research, a very broad search strategy was used, using
a reduced number of combinations to increase the number of
initial hits.
All results were screened for duplicates. In the next
stage, results were screened based on the title and abstract
only, and the full texts of potentially relevant studies were
subsequently assessed. Relevant information was tabulated
in evidence tables.
Study designs were divided into the following categories:
(1) prospective studies of dengue cases, (2) studies analyz-
ing post-hoc existing prospectively collected databases of
dengue cases, (3) studies reviewing retrospectively existing
medical charts of dengue cases, and (4) acceptability studies
(mostly of qualitative design).
No studies were excluded in the analysis for quality rea-
sons if the eligibility criteria were met, but limitations and
possible biases are reported in the results section. The analy-
sis followed the categories according to the use of the case
classification: (1) clinical use (establishing severe dengue dis-
ease using WS for identifying severe dengue disease, detect-
ing dengue, usefulness for triage, usefulness for outbreaks,
and ease of application by clinicians), (2) use in surveillance
detecting dengue cases and detecting dengue outbreaks as
well as reporting of the different levels of severity of dengue
disease (D/SD), and (3) use in research.
RESULTS
In total, 782 studies were identified during the electronic
search that were potentially relevant to the research ques-
tion, including duplicates. After the screening of titles and
abstracts, 25 studies remained eligible.10–34 Eligible studies
are tabulated in Table 1. Ten studies22–31 were relevant to
the research question based purely on expert opinion, with-
out stating a particular methodology as to how the results
were derived. These studies were excluded from the analy-
sis but reflected in the discussion for the purpose of high-
lighting the different opinions. Three additional studies were
excluded after full assessment of the text, because they only
assessed DF/DHF/DSS without comparison with D/SD32,33
or dealt with a particular subgroup of cases not representa-
tive of dengue-endemic countries (dengue in travellers34).
Of the remaining 12 studies,10–21 11 studies were from
published databases, and one study was from grey literature.
No other studies were identified from the reference lists.
Figure 1 summarizes the process of selection in a flowchart.
All studies were published after 2009—the date set for
initiating the search. Most of the studies included (prospec-
tive, post-hoc analysis of existing datasets or review of
existing medical charts, and any qualitative design) were
performed in Asia, with the exception of three studies: one
study that included 18 study sites worldwide,10 one study
from Nicaragua,16 and one study from Peru.18 Studies10–13
are prospective studies published between 2010 and 2013.
All other studies used datasets either prospectively devel-
oped and compared post-hoc with the use of D/SD and
DF/DHF/DSS or retrospectively derived from case notes
of dengue-positive cases developed over time and without
a strict study protocol. One study10 also included the accept-
ability of the different dengue case classifications with quali-
tative methods.
Sample sizes of the studies10–21 were relatively small, rang-
ing from 50 to 300 cases (mostly less than 100 cases), with the
exception of three studies10,17,20 with more than 1,000 cases
each. Most of the studies included adults and children; only
three studies were confined to pediatric centers.12,16,21
All studies were performed in hospital settings of either
secondary or tertiary level hospitals. The study in ref. 10—
with 18 study sites—had the biggest scale in case numbers
and the most comprehensive scope with all levels of
healthcare delivery systems included in Asian as well as
Latin American countries.
Studies often addressed multiple questions; the following
results are presented according to the categories described
in the methods sections. In general, the prospectively col-
lected studies are largely in favor of the use of D/SD in the
clinical setting; the retrospective studies have similar results,
apart from the study in ref. 15
Clinical use. Which classification describes the clinical
picture of dengue cases better? The studies dealing with this
question all agree that D/SD classifies dengue as it occurs
clinically. The study in ref. 10 in 18 countries with the biggest
sample overall concludes that “13.7% of cases could not
be classified according to DF/DHF/DSS (missing data e.g.
haematocrit, platelet counts, and tourniquet tests on > 50%
of charts), compared to 1.6% for D/SD. 32.1% of severe
dengue cases could not be classified in the DF/DHF/DSS
system.” The study in ref. 17, also in a large sample, recon-
firms that “DF/DHF/DSS and D/SD were discordant in
defining severe disease (p: 0.001).” D/SD describes severe
disease, whereas DF/DHF/DSS describes severe disease less
well. Similarly, findings in the study in ref. 19 are “a cross
tabulation [that] showed DF cases were distributed in all
of the severity groups stratified by D/D+WS/SD (53.8%
Group D/45.4% Group D+WS/0.8% Group SD). Of the
DHF cases, 23 (79%) were categorized as Group D+WS,
and six (20.7%) as Group SD.”
When looking at quality of studies, the studies in refs. 10,
17, and 19 of this systematic literature review provide proba-
bly the best available quantitative evidence for this question.
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































COMPARING THE 1997 AND 2009 WHO DENGUE CASE CLASSIFICATIONS 629
Identifying dengue (case definition). Only one study dealt
with the question of whether the case definitions for D are
more useful to detect dengue compared with DF.14 The
results—retrospectively based on 164 dengue cases com-
pared with 200 other febrile illnesses (OFIs)—show for DF
(as defined by the DF/DHF/DSS classification) a sensitivity
of 95.4% and a specificity of 36.0% and for D (as defined by
the D/SD classification) a sensitivity of 79.9% and specificity
of 57.0%. The study acknowledges that D/SD was not primar-
ily designed for detecting dengue. When using an NS1 test, the
sensitivity and specificity for both dengue case classifications
improve considerably (Table 1).
Identifying severe disease (case classification). Several studies
looked at sensitivity and specificity of D/SD and DF/DHF/
DSS for identifying severe dengue. Sensitivity for detection of
severe disease has been calculated by five studies,11,13,16,18,21
with results in the range from 59% to 98% for SD (as defined
by the D/SD classification). The prospective studies11,13 esti-
mate sensitivity at 88% and 98%, respectively. Specificity is
estimated between 41% and 99% (99% for the prospective
study presenting values11). Sensitivity and specificity for
DHF (as defined by the DF/DHF/DSS classification) range
between 24.8% and 89.9% and between 25% and 100%,
respectively (sensitivity of 24.8% and 74% for the prospec-
tive studies and 100% specificity for the prospective study
presenting data) (Table 2).
In summary, comparing DF/DHF/DSS with D/SD, it seems
that, in most studies, D/SD turned out to be better in terms
of sensitivity and specificity for distinguishing D and SD,
which is summarized in the study in ref. 10 (here derived
from qualitative data: “the revised classification also proved
to be more sensitive for timely recognition of severe disease”).
WS for SD disease. Several studies looked at the value
of WS as predictors of severe disease. The study in ref. 11
suggests that having at least five WS may be a good pre-
dictor of severe disease; in particular, lymphocyte counts
< 1,500 cells/mm3, platelet counts < 20,000/mm3, and raised
AST levels were associated with SD. However, in the study
in ref. 20, the three most common WS were lethargy,
abdominal pain/tenderness, and mucosal bleeding. Also, no
single WS alone or combined had a sensitivity of more than
64% in predicting severe disease.20 Specificity was 90% for
both DHF and SD with persistent vomiting, hepatomegaly,
hematocrit rise, and rapid platelet drop.20
In practice, however, it seems that WS are significant
events that are well-documented in medical charts,10 but
using WS as compulsory hospitalization criteria may well
increase workload.
Usefulness for triage and in outbreaks. The study in ref. 10
finds—with focus groups and questionnaires among clini-
cians in 18 countries—that D/SD “was easily applicable in
clinical practice, also seen to be useful for triage and case
management by medical staff, more frequently than the
DF/DHF/DSS classification.” The study in ref. 15 analyses
medical charts of 274 confirmed dengue cases. When using
DF/DHF/DSS, more intensive treatment (with careful moni-
toring and intravenous rehydration) was needed in 94 cases
compared with 189 cases when using D+WS and SD as
criteria. Similarly, the study in ref. 17 calculates the require-
ment for hospitalization increasing from 17.0% to 51.3%
using D/SD. This finding is in agreement with the findings


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































630 HORSTICK AND OTHERS
resources with its more stringent definition of a DHF case
requiring the most intensive hospital intervention.” How-
ever, the same study points out that “the use of D/SD
guidelines in this outbreak facilitated the early admission
of those with life threatening dengue disease for appropriate
clinical management.”
Ease of application by clinicians. Only two studies assessed
the ease of application by health personnel, with positive
results overall for the D/SD classification: the study in ref. 10
shows, with questionnaires and focus groups, that D/SD was
easily applicable in clinical practice more frequently than
the DF/DHF/DSS classification; the former was also seen
to be useful for triage and case management by medical
staff. The study in ref. 16 analyzed with interrater agree-
ment methods how clinicians agreed with each other when
classifying the same cases according to either D/SD or
DF/DHF/DSS; the former had substantial agreement (k = 0.62,
P = 0.001), and the latter had moderate agreement (k = 0.46,
P = 0.001).
Use in surveillance and research. No study examined the
use of D/SD compared with DF/DHF/DSS in the context
of dengue surveillance and/or reporting; the study in ref. 10
argued that, with the improved description of cases and
especially, the improved sensitivity for severe cases, data
Figure 1. Flowchart of the systematic search for literature.
Table 2
Reported sensitivities and specificities for dengue severity
Ref. Authors Place Pro/Retro Sample size
D/SD (%) DF/DHF/DSS (%)
CommentsSensitivity Specificity Sensitivity Specificity
11 Basuki and others Indonesia Pro 145 88 99 74 100 Using a “clinical intervention tool”
13 Prasad and others India Pro 56 98 NR 24.8 NR Comparing with “treatment levels”
16 Narvaez and others Nicaragua Retro 544 92.1 78.5 39.0 75.5 Comparing with “clinical intervention levels”
18 Siles and others Peru Retro 92 59 41 0 98 Comparing with “hospital level of care”
21 Van de Weg
and others
Indonesia Retro 173 70.5 79.5 89.9 25 Comparing with “intensive
treatment intervention”
NR = not reported; Pro = prospective; Retro = retrospective.
COMPARING THE 1997 AND 2009 WHO DENGUE CASE CLASSIFICATIONS 631
collection for epidemiological returns should be improved.
However, the study in ref. 16 concludes that the use in
epidemiology needs to be evaluated.
No study addressed whether D/SD has advantages or
disadvantages for research. The study in ref. 16 states that
its use in pathophysiological and epidemiological studies needs
additional evaluation.
Because there were no studies identified that formally
evaluated D/SD compared with DF/DHF/DSS in these areas,
we refer to the discussion section below, where expert opinions/
viewpoints were also included.
Additional results. Most studies conclude that additional
research needs to address unsolved questions, especially in
larger studies (locally adapted case definitions for diagnosing
dengue in the absence of confirmatory laboratory testing
and the predictive value of WS in outpatients and inpa-
tients) and different settings.11,12
It has also been emphasized that training needs to be
addressed as well as the development of local clinical proto-
cols for dengue.
DISCUSSION
Limitations. Because D/SD was only introduced in 2009,
the number of studies available is surprising, probably under-
lining the importance of this question. Nevertheless, the
number of studies available for answering the study question
was limited, and therefore, all available data in this study,
including lower-quality studies and retrospective studies,
had to be considered in this review. Only very few prospec-
tive studies are available, and even fewer qualitative studies
have been reported. Regarding the quality of retrospective
studies, it is often unclear if all data are available retrospec-
tively to conduct such studies. Also, almost all studies
reviewed are on a secondary or tertiary level of care and not
primary care. Most studies are not in resource-poor settings.
Furthermore, sample sizes are mostly small, and data from
Asian countries prevail.
Publication bias is another concern, especially for the
expert opinion papers; therefore, they have been excluded
from the analysis and are mentioned only in the discussion.
Relative value of the two dengue case classifications. The
first question is which purpose does the classification serve:
clinical care, surveillance, or research (see also ref. 29). In
this section, we will consider these three main areas of appli-
cation of the dengue case classification.
For the clinical use of D/SD, the three prospective studies
dealing with this question confirm that D/SD has advan-
tages in defining the severity of dengue cases.10,11,13 The
evidence is even stronger when considering sample size. The
study in ref. 10 is, by far, the biggest study in this context,
conducted globally in 18 different dengue-affected coun-
tries, and the study in ref. 11 is a medium-sized study. The
sensitivity and specificity analyses11,13,16,18,21 are equally
in favor of D/SD. However, this finding is no surprise,
because the classification has been designed4 “to develop
a revised evidence-based classification that would better
reflect clinical severity.”
The ability to distinguish D and SD—as it currently occurs
globally—is probably the biggest advantage of D/SD.
Expert opinion underlines this finding. The studies in
refs. 26 and 29 argue—mainly with reference to the study
by Alexander and others4 and the study in ref. 10—that
D/SD offers a better categorization than the DF/DHF/
DSS classification.
In a letter responding to study,13 it has been queried
whether the classification is useful for predicting dengue
severity and also, if the application of the classification can
be considered to have an easy application.31
Clinical use of the classification also includes the use of
WS. It would be beneficial to have robust and validated
WS, but the level of evidence for most WS as established
in D/SD is not very high, because large quantitative studies
are needed to establish the validity of single parameters
and/or combinations of parameters in predicting the prog-
ress to SD. This finding has been acknowledged by the
two quantitative studies dealing with this question12,20 and
the expert opinions: responding to the study in ref. 20, it
has been mentioned that convincing studies about WS
need to be prospective and should include primary care.30
The WS, as defined in the D/SD framework, were consid-
ered to require more specific definitions.22 Currently, large
global prospective studies are under way to help improve
the knowledge of the value of WS (International Research
Consortium on Dengue Risk Assessment, Management
and Surveillance study (IDAMS) at http://ichgcp.net/clinical-
trials-registry/NCT01550016 and Laboratory Diagnosis and
Prognosis of Severe Dengue study at http://ichgcp.net/clinical-
trials-registry/NCT01421732).
The dengue case definition is important for diagnosing a
dengue case, especially when diagnosing without laboratory
confirmation in resource-poor settings.14 The D/SD frame-
work uses the same criteria for case definitions as defined
by the DF/DHF/DSS framework (which is based on expert
opinion), with some modifications also driven by expert
opinion. However, it is well-known that using only clinical
criteria for discriminating between different febrile illnesses
is difficult or impossible. Similar to the WS, this question
can only be addressed with large prospective global studies,
which are under way (IDAMS study above).
This finding leads to the question of whether a clinically
based dengue diagnosis and the application of WS can be
useful for triage. Some studies, based on qualitative argu-
ments10 and expressing the viewpoints of clinicians, come to
a positive answer; others refer to the fact that the ease of
application is also documented in studies.16 One retro-
spective study argues that the caseload for hospitalization
increases dramatically.15 However, the same study acknowl-
edges that only 68% of cases with SD disease can be clas-
sified with the DF/DHF/DSS framework. In other words,
32% of cases are not classifiable and maybe missed, reflecting
the low sensitivity of DHF. This result has been summarized
in the study in ref. 18, which acknowledges that the work-
load may potentially increase with the broad use of WS but
that cases with severe disease are correctly identified. It
seems that the application of the WS in the algorithm needs
adjustment to the locally available resources, which was men-
tioned in the WHO guidelines1: “depending on the clinical
manifestations and other circumstances, patients may . . . be
referred for in-hospital management (Group B).” Whether
increased admissions with early treatment may reduce severe/
fatal illnesses needs to be analyzed as well.
The expert opinion papers vary on this issue. One study22
supports the view that D/SD is beneficial for triage; another
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study31 reports the excellent experience of using D/SD for
grouping of patients for additional management.
It would be useful to see more studies using the algo-
rithms for treatment as suggested in the WHO guidelines1
and the Clinical Handbook on Dengue Management,9 with
local adaptations in prospective studies—maybe in outbreak
situations—and use of qualitative methods to assess the
usefulness of D/SD in real-life circumstances.
No quantitative studies assessed the use of the D/SD versus
the DF/DHF/DSS classification in dengue surveillance and
case reporting. However, the difficulties in applying DF/
DHF/DSS led to the development of multiple local adapta-
tions and put global comparability at risk. Studies assessing
the use of D/SD in clinical settings argued that the improved
description of dengue as it occurs globally, leading to more
specific categorizations according disease severity, should
lead to improved reporting. Likewise, the opinion-based
papers in this systematic review argue that D/SD23 “maybe
useful for surveillance and reporting” and provide the oppor-
tunity of improved international comparison of data.26 How-
ever, to confirm this answer, additional research is warranted.
For the use of the D/SD classification as an outcome in
basic research or pathogenesis research, no quantitative data
were available.
A viewpoint/opinion paper24 argues that “pathogenesis
research should be conducted as much as possible on care-
fully defined categories of human disease response. This
requires splitting, not lumping.” This work was responded
to by a group of authors29 arguing that “DF/DHF/DSS was
too complicated to use in clinical or public health settings,
yet was not sufficiently precise for detailed pathogenesis
studies” and that “D/SD brings clarity, clinical and epide-
miological utility, and the potential for development of more
precise definitions of clinical phenotype for pathogenesis
studies.” Therefore, D/SD, with its three severity markers—
severe plasma leakage, severe bleeding, and severe organ
manifestation—can be further refined for basic research.
Two other views were expressed: (1) quantitative studies
confirmed that the DF/DHF/DSS framework does not reflect
levels of severity10,17,19; and (2) critical evaluation of D/SD is
limited to the use in basic research; however, this critical eval-
uation is not based on specific studies, but is based on expert
opinion only.23,24,27
Some studies suggest solutions—based on their analysis—
to reclassify the dengue disease classifications (for example,
introducing subgroups for dengue with organ failure). How-
ever, it has to be underlined that these suggested solutions
are based on each individual study presenting individual
solutions15,17 and not the result of the highest available evi-
dence for the particular study question, the latter being one
of the strengths of D/SD.25
In conclusion, this systematic review confirms—almost
5 years after its introduction—that the D/SD classification
is able to detect disease severity with high sensitivity, thus
assisting clinical management and potentially, contributing to
reducing dengue mortality.
The limitation of not having more appropriate studies avail-
able is also a result of this study, with the urgent call for studies
to be designed prospectively and include primary care.
Diagnosis of dengue by clinical parameters only continues
to be a challenge. It is recommended to await the findings
of the ongoing large clinical studies for a possible adap-
tation of case definitions and WS. Furthermore, it is rec-
ommended to study the performance of D/SD for triage,
especially in outbreak situations. For surveillance and global
reporting, a unified classification system with accurate infor-
mation on disease severity would be advantageous.
For pathogenesis research, the D/SD classification may open
new opportunities, with a fresh look at underlying pathology
now that the spectrum of disease is better described.
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